Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.

In order to clarify the molecular mechanism involved in renal carcinogenesis, and to identify molecular targets for diagnosis and treatment, we analyzed genome-wide gene expression profiles of 15 surgical specimens of clear cell renal cell carcinoma (RCC), compared to normal renal cortex, using a combination of laser microbeam microdissection (LMM) with a cDNA microarray representing 27,648 genes. We identified 257 genes that were commonly up-regulated and 721 genes that were down-regulated in RCCs. None of top 24 up-regulated genes that showed most significant differences in informative RCC-cases were included in previous reports describing expression profiles of RCC using RNAs isolated from bulk tissues. These findings suggest that it is important to purify as much as possible the populations of cancerous and normal epithelial cells obtained from surgical specimens. Among the significantly-transactivated genes, we focused on Semaphorin 5B (SEMA5B) and knocked-down its expression in RCC cells by small-interfering RNA (siRNA). Effective down-regulation of its expression levels in RCC cells significantly attenuated RCC cell viability. In conclusion, our data should be helpful for a better understanding of the tumorigenesis of RCC and should contribute to the development of diagnostic tumor markers and molecular-targeting therapy for patients with RCC.

[1]  W. Stadler.  Targeted agents for the treatment of advanced renal cell carcinoma , 2005, Cancer.

[2]  O. Ogawa,et al.  The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. , 2005, The Journal of urology.

[3]  Yusuke Nakamura,et al.  Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. , 2005, Cancer research.

[4]  Bin Tean Teh,et al.  Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. , 2005, International journal of oncology.

[5]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[6]  H. Tabuchi,et al.  Gene expression analysis of renal carcinoma: adipose differentiation‐related protein as a potential diagnostic and prognostic biomarker for clear‐cell renal carcinoma , 2005, The Journal of pathology.

[7]  Shinzaburo Noguchi,et al.  mRNA expression level of estrogen‐inducible gene, α1‐antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers , 2004, Cancer science.

[8]  M. Gleave,et al.  Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. , 2004, The Journal of urology.

[9]  Gil Ohana,et al.  The A3 Adenosine Receptor Is Highly Expressed in Tumor versus Normal Cells , 2004, Clinical Cancer Research.

[10]  Zhong-Hui Duan,et al.  Microarray gene expression profiling and analysis in renal cell carcinoma , 2004, BMC urology.

[11]  David W. Johnson,et al.  The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. , 2004, Kidney international.

[12]  Gary L Clayman,et al.  Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. , 2003, Archives of otolaryngology--head & neck surgery.

[13]  M. Terris,et al.  Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. , 2003, The American journal of pathology.

[14]  A. Skubitz,et al.  Differential gene expression in renal-cell cancer. , 2002, The Journal of laboratory and clinical medicine.

[15]  M. Toyota,et al.  Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors , 2002, Oncogene.

[16]  K. Furge,et al.  Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  F. Marshall,et al.  Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. , 2001, The American journal of pathology.

[18]  A. Harris,et al.  A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  T Tanaka,et al.  Identification by cDNA microarray of genes involved in ovarian carcinogenesis. , 2000, Cancer research.

[20]  Alamdari,et al.  Follow‐up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy , 1999, BJU international.

[21]  C. Bokemeyer,et al.  Chemotherapy for renal cell carcinoma. , 1999, Anticancer research.

[22]  R. DePinho,et al.  Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Evdokiou,et al.  Tumor‐suppressive activity of the growth arrest‐specific gene GAS1 in human tumor cell lines , 1998, International journal of cancer.

[24]  B. Delahunt,et al.  Classification of renal cell carcinoma , 1997, Cancer.

[25]  C. Goodman,et al.  The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules , 1993, Cell.

[26]  P. Comoglio,et al.  To move or not to move? Semaphorin signalling in cell migration. , 2004, EMBO reports.

[27]  M. Kasuga,et al.  Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-1 (E-NPP1/PC-1) , 2004 .

[28]  中村 透.  Genome-wide cDNA microarray analysis of gene-expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection , 2004 .

[29]  Yusuke Nakamura,et al.  Advances in Brief Involvement of the FGF 18 Gene in Colorectal Carcinogenesis , as a Novel Downstream Target of the-Catenin / T-Cell Factor Complex 1 , 2003 .

[30]  M Vingron,et al.  Identification and Classification of Differentially Expressed Genes in Renal Cell Carcinoma by Expression Profiling on a Global Human 31 , 500-Element cDNA Array , 2001 .

[31]  M. Karno,et al.  Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.